Professional Documents
Culture Documents
LEARNING OUTCOMES
At the end of the chapter, students must have:
1. Recognized the di erences of innate from adap ve immune system;
2. Examined the func ons of the di erent immunoglobulins;
3. Dis nguished from each other the mechanisms involved in the various types of
hypersensi vity reac ons, ci ng examples of each type; and
4. Explained the role of vaccines in the preven on of the development of infec ous
diseases.
WARM-UP ACTIVITY
Think of a food that you love but is most o en disliked.
CENTRAL ACTIVITIES
Learning Input 1 (Lecture)
Speci c Host Defense
• The immune system is considered to be the third line of defense.
• It is considered a speci c host defense mechanism because it springs into ac on to
defend against a speci c pathogen (or other foreign object) that has gained entrance
to the body.
Immunology
• The scien c study of the immune system and immune responses.
An gens
• Molecules that s mulate a person’s immune system to produce an bodies.
An bodies
• Proteins produced by the immune system in response to an gens.
ff
ti
ti
ti
fi
ti
ti
ti
fi
ti
ti
fi
ti
ff
ti
ti
fi
fi
ti
tt
ti
ff
ti
ti
ti
ti
ti
ti
ft
ti
ti
fi
ti
ti
Major Arms of the Immune System
1. Humoral Immunity/An body-Mediated Immunity (AMI)
• Always involves the produc on of an bodies in response to an gens.
• A er their produc on, these humoral (circula ng) an bodies
remain in blood plasma, lymph, and other body secre ons where they protect
against the speci c pathogens that s mulated their produc on.
• Thus, in humoral immunity, a person is immune to a par cular pathogen
because of the presence of speci c protec ve an bodies that are e ec ve
against that pathogen.
2. Cell-Mediated Immunity (CMI)
• Involves many di erent cell types, including macrophages, T helper cells,
cytotoxic T cells, delayed hypersensi vity T cells, natural killer cells, killer cells,
and granulocytes.
• Although an bodies may play a role in some types of cell-mediated immune
reac ons, they do not play a major role.
Immunity
1. Acquired Immunity
• Immunity that results from the ac ve produc on or receipt of protec ve
an bodies during one’s life me.
a. Ac ve acquired immunity
• If the an bodies are actually produced within the person’s body.
ti
ti
ti
ti
fi
ti
ti
ff
ti
ti
ti
ti
ti
fi
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ff
ti
ti
ti
ti
ff
ti
ti
ff
ti
ti
ti
i. Natural Ac ve Acquired Immunity
• People who have had a speci c infec on usually have
developed some resistance to reinfec on by the
causa ve pathogen because of the presence of
an bodies and s mulated lymphocytes.
ii. Ar cial Ac ve Acquired Immunity
• Results when a person receives a vaccine.
b. Passive acquired immunity
• The person receives an bodies that were produced by another
person or by more than one person, or, in some cases, by an animal;
such protec on is usually only temporary.
i. Natural Passive Acquired Immunity
• Small an bodies (like immunoglobulin G [IgG], present in
the mother’s blood cross the placenta to reach the fetus
while it is in the uterus (in utero).
• Colostrum, the thin, milky uid secreted by mammary
glands a few days before and a er delivery, contains
maternal an bodies to protect the infant during the rst
months of life.
ii. Ar cial Passive Acquired Immunity
• Accomplished by transferring an bodies from an
immune person to a suscep ble
person.
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
fl
ti
ti
ti
ti
fi
ti
ft
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
fi
ti
ti
ft
tt
ti
ti
c. Type III Hypersensi vity Reac ons/Immune Complex Reac ons
• Include serum sickness and certain autoimmune diseases (e.g.,
systemic lupus erythematosus [SLE] and rheumatoid arthri s).
• These reac ons involve IgG or IgM an bodies, complement,
and neutrophils.
2. Type IV Hypersensi vity Reac ons/Delayed Hypersensi vity (DTH)/Cell-
mediated Immune Reac ons
• They are usually observed 24 to 48 hours or longer a er exposure or
contact.
• They occur in tuberculin and fungal skin tests, contact derma s, and
transplanta on rejec on.
Autoimmune Diseases
• Results when a person’s immune system a acks the person’s body ssues as if they
were nonself or foreign.
• Such ssues may include the lens of the eye, the brain and spinal cord, and sperm.
• Subsequent exposure to this ssue (by surgery or injury) may allow an bodies (IgG or
IgM) to be formed, which together with complement could cause destruc on of these
ssues, resul ng in blindness, allergic encephali s, or sterility.
Ac vity 1
You are expected to par cipate in the online lecture on December 1, 2020 (Tuesday;
8:00am-8:30am for Level IIA and 9:00am-9:30am for Level IIB).
Ac vity 2
You are expected to par cipate in the online lecture on December 1, 2020 (Tuesday;
8:30am-9:00am for Level IIA and 9:30am-10:00am for Level IIB).
WRAP-UP ACTIVITY
Summarize what you have learned or how your new learnings has changed your
thoughts on the topic.
ti
ti
ti
ti
ti
ti
ti
ti
ti
fi
ti
ti
ti
ti
tt
ti
ft
ti
ti
ti
ti
ti
ti
ti
fi
ti
ti
ti
ti
ti
POST-ASSESSMENT
Worksheet 11 (Lecture)
You are required to accomplish the Worksheet 11. The ac vity will be posted on
December 1, 2020 (Tuesday) in the mVLE course page. Make sure to complete and submit
your output on or before 11:59 pm December 6, 2020 (Sunday).
Worksheet 11 (Laboratory)
You are required to accomplish the Worksheet 11. The ac vity will be posted on
December 1, 2020 (Tuesday) in the mVLE course page. Make sure to complete and submit
your output on or before 11:59 pm December 6, 2020 (Sunday).
Quiz 11
You are required to take the Quiz 11. The quiz will be posted on December 1, 2020
(Tuesday) a er the online lecture in the mVLE course page. Make sure to complete and
submit your output on or before 11:59 pm December 1, 2020 (Tuesday).
ft
ti
ti